Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Communications
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Juntendo Educational Foundation holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio has 5 pending office actions currently in progress. These actions are distributed among 5 distinct examiners, showing a high degree of examiner variety relative to the total volume of applications. This distribution means that each pending action is being reviewed by a different individual. The presence of 5 pending office actions indicates a significant level of ongoing administrative activity.
The prosecution activity spans 4 distinct art units, which suggests the portfolio covers several different technical sub-specialties. Nelson C Lam is the busiest examiner, although he is only responsible for 1 busiest examiner pending office action. This distribution indicates that no single examiner dominates the current workload, as the 5 distinct examiners each handle a portion of the filings. Practitioners should prepare for diverse examiner perspectives across the 4 distinct art units involved in these proceedings.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAM, NELSON C | 1 | 60.3% | +8.8% |
| TEJANI, ANKIT D | 1 | 81.0% | +16.9% |
| DRISCOLL, LORA E BARNHART | 1 | 32.0% | +20.0% |
| COPPINS, JANET L | 1 | 72.6% | +26.1% |
| SCHLOOP, ALLISON ELIZABETH | 1 | 63.0% | +56.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269510 | COMPOUND, COMPOSITION, BIOTISSUE EMBRITTLEMENT AGENT, BIOTISSUE SURFACE DETACHMENT METHOD, AND BIOTISSUE DETACHMENT KIT | COPPINS, JANET L | 46d overdue |
| 19116092 | VISUAL ACUITY TRAINING SYSTEM, VISUAL ACUITY TRAINING METHOD, AND PROGRAM | LAM, NELSON C | 8d overdue |
| 18871971 | METHOD FOR TREATING PARKINSON'S DISEASE THROUGH PHOTOSTIMULATION, AND DEVICE USED IN SAID METHOD | TEJANI, ANKIT D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269510 | COMPOUND, COMPOSITION, BIOTISSUE EMBRITTLEMENT AGENT, BIOTISSUE SURFACE DETACHMENT METHOD, AND BIOTISSUE DETACHMENT KIT | COPPINS, JANET L | 46d overdue |
| 17924640 | METHOD FOR DETECTING PARKINSON'S DISEASE | SCHLOOP, ALLISON ELIZABETH | 38d overdue |
| 18414545 | THERAPEUTIC AGENT FOR MALIGNANT TUMORS EXPRESSING MHC CLASS II | DRISCOLL, LORA E BARNHART | 8d |
| 18871971 | METHOD FOR TREATING PARKINSON'S DISEASE THROUGH PHOTOSTIMULATION, AND DEVICE USED IN SAID METHOD | TEJANI, ANKIT D | — |
| Art Unit | Apps |
|---|---|
| 2627 | 1 |
| 3991 | 1 |
| 1628 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19116092 | VISUAL ACUITY TRAINING SYSTEM, VISUAL ACUITY TRAINING METHOD, AND PROGRAM | LAM, NELSON C | 2627 | §102§103§112 | Final Rejection | 8d overdue | Pending | May 02, 2025 |
| 18871971 | METHOD FOR TREATING PARKINSON'S DISEASE THROUGH PHOTOSTIMULATION, AND DEVICE USED IN SAID METHOD | TEJANI, ANKIT D | — | §102§103Other | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18414545 | THERAPEUTIC AGENT FOR MALIGNANT TUMORS EXPRESSING MHC CLASS II | DRISCOLL, LORA E BARNHART | 3991 | §112Other | Non-Final OA | 8d | Pending | Jan 17, 2024 |
| 18269510 | COMPOUND, COMPOSITION, BIOTISSUE EMBRITTLEMENT AGENT, BIOTISSUE SURFACE DETACHMENT METHOD, AND BIOTISSUE DETACHMENT KIT | COPPINS, JANET L | 1628 | §102§112 | Final Rejection | 46d overdue | Pending | Jun 23, 2023 |
| 17924640 | METHOD FOR DETECTING PARKINSON'S DISEASE | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Non-Final OA | 38d overdue | Pending | Nov 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial